| CAS NO: | 2020015-37-4 |
| 包装: | 50mg, 100mg, 250mg |
| 规格: | ≥98% |
DY3002 is a novel Selective and Potent EGFR Inhibitor, Overcoming T790M-Mediated Resistance in Non-Small Cell Lung Cancer. References: Li Y, Song Z, Jin Y, Tang Z, Kang J, Ma X. Novel Selective and Potent EGFR Inhibitor that Overcomes T790M-Mediated Resistance in Non-Small Cell Lung Cancer. Molecules. 2016 Nov 2;21(11). pii: E1462. PubMed PMID: 27827863.
纯度：≥98%
CAS：2020015-37-4
m.cnreagent.com